This site is intended for healthcare professionals

Esmya (ulipristal acetate): suspension of the licence

Posted 3 Apr 2020

Dr Julie Oliver

Julie Oliver summarises information from the MHRA regarding the suspension of the licence for Esmya (ulipristal acetate) while a safety review is conducted.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page